Supplement update IE00BLCHJB90 & IE00BLCHJC08

This document is important and requires your immediate attention. If you are in any doubt as to the action you should take, you should seek advice from your investment consultant or other professional advisors.

This document has not been reviewed by the Central Bank of Ireland (the "Central Bank").

If you have sold or transferred all of your shares in Global X Robotics & Artificial Intelligence UCITS ETF (the "Fund") please pass this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee as soon as possible.

Capitalised terms used herein shall bear the same meaning as defined in the prospectus of Global X ETFs ICAV (the "ICAV) dated 4 September 2023, as amended by addenda thereto

dated 24 October 2023, (collectively, the "Prospectus") and the supplement in respect of the Fund, dated 12 January 2024 (the "Supplement"). Copies of the Prospectus and Supplement are available upon request during normal business hours from the registered office of the ICAV.

13 February 2024

RE:   Notification of amendments to the Supplement of the Fund.

Dear Investors

The ICAV is an open-ended investment vehicle with variable capital organised under the laws of Ireland and is authorised by the Central Bank pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, as amended.  The Fund is a sub-fund of the ICAV.

It is proposed that the Supplement of the Fund be changed as set out below:

Investment Policy

In order to achieve this investment objective, the Fund will seek to replicate the performance of the Index, subject to the deduction of the TER and other expenses associated with operating the Fund as further described in the "Fees and Expenses" section of the Prospectus. It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the Index. By holding each equity security in approximately the same proportion as its weighting in the Index, the Fund may have exposure to or invest up to 20% of the Net Asset Value of the Fund in stocks issued by the same body. This limit may be raised to 35% for a single issuer in exceptional market conditions which may include the dominance of a particular issuer in the relevant market.

The proposed changes outlined above necessitate that the Supplement be updated accordingly and these updates to the Supplement will take effect on, or around, 28 February 2024, subject to the approval of the Central Bank.

Should you have any questions relating to the changes detailed above, you should contact your local

agent, or (if none) Global X ETFs on +44 (0)20 4529 2551 or [email protected], or alternatively you should contact your investment consultant, tax adviser and/or legal adviser as

appropriate.

Yours faithfully,

_______________

Director

For and on behalf of

Global X ETFs ICAV